A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...

In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...